4/18
07:30 am
tgtx
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Medium
Report
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
4/18
07:23 am
tgtx
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis [Yahoo! Finance]
Medium
Report
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis [Yahoo! Finance]
4/18
07:00 am
tgtx
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
Low
Report
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
4/17
10:51 am
tgtx
TG Therapeutics: The Cloud Over Briumvi [Seeking Alpha]
Low
Report
TG Therapeutics: The Cloud Over Briumvi [Seeking Alpha]
4/15
07:30 am
tgtx
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Low
Report
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
4/12
07:07 pm
tgtx
TG Therapeutics: BRIUMVI Development Could Lead To Great Results [Seeking Alpha]
Low
Report
TG Therapeutics: BRIUMVI Development Could Lead To Great Results [Seeking Alpha]
3/22
03:30 am
tgtx
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against TG Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Low
Report
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against TG Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
3/21
01:18 pm
tgtx
PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain [Yahoo! Finance]
Neutral
Report
PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain [Yahoo! Finance]
3/19
07:28 am
tgtx
Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals? [Yahoo! Finance]
Low
Report
Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals? [Yahoo! Finance]
3/8
07:30 am
tgtx
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Medium
Report
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
3/1
09:00 am
tgtx
TG Therapeutics: Briumvi Growth Story Appears Intact [Seeking Alpha]
Low
Report
TG Therapeutics: Briumvi Growth Story Appears Intact [Seeking Alpha]
3/1
07:46 am
tgtx
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum [Yahoo! Finance]
Medium
Report
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum [Yahoo! Finance]
3/1
07:30 am
tgtx
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Medium
Report
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
2/29
09:33 am
tgtx
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/29
08:17 am
tgtx
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $12.00 to $13.00. They now have a "neutral" rating on the stock.
Low
Report
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $12.00 to $13.00. They now have a "neutral" rating on the stock.
2/28
01:10 pm
tgtx
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
Low
Report
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $45.00 price target on the stock.
2/28
10:10 am
tgtx
TG Therapeutics jumps after second consecutive quarterly beat [Seeking Alpha]
Low
Report
TG Therapeutics jumps after second consecutive quarterly beat [Seeking Alpha]
2/28
09:33 am
tgtx
TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Neutral
Report
TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
2/28
08:14 am
tgtx
TG Therapeutics Inc (TGTX) Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
High
Report
TG Therapeutics Inc (TGTX) Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
2/28
07:10 am
tgtx
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results [Yahoo! Finance]
High
Report
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results [Yahoo! Finance]
2/28
07:00 am
tgtx
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
High
Report
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
2/27
07:38 am
tgtx
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy) [Yahoo! Finance]
Medium
Report
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy) [Yahoo! Finance]
2/27
07:30 am
tgtx
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
Medium
Report
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
2/26
07:07 am
tgtx
TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy) [Yahoo! Finance]
Low
Report
TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy) [Yahoo! Finance]
2/26
07:00 am
tgtx
TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)
Low
Report
TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)